Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors-MedSci.cn

Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors

Wu, MZ; Chandramouli, C; Wong, PF; Chan, YH; Li, HL; Yu, SY; Tse, YK; Ren, QW; Yu, SY; Tse, HF; Lam, CSP; Yiu, KH

Yiu, KH (通讯作者)，Univ Hong Kong, Shenzhen Hosp, Dept Med, Div Cardiol, Shen Zhen, Peoples R China.;Yiu, KH (通讯作者)，Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Peoples R China.;Lam, CSP (通讯作者)，Natl Heart Ctr Singapore, Singapore, Singapore.

Abstract

Aim: The organ protective effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors may be beneficial against infectious complications. This real-w......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors

科室

工具

服务